CME Group gets upgraded to buy, from my prior hold rating over a year ago, with renewed confidence in its future top and bottom-line growth potential. The firm could be driven by increased trading volume, but also growing demand for data analytics solutions. The dividend case is strong: a +4% yield, proven dividend growth, and a safe payout ratio.
Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess have been highlighted in this Industry Outlook article.
Share buyback authorizations are useful indicators to stay aware of. Share buybacks are often thought of as an indirect return of capital to shareholders.
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
A strong global presence, a compelling product portfolio, focus on over-the-counter clearing services and a solid capital position poise CME Group well for growth.
In today's uncertain market, it's vital to find stocks that can provide both income and stability. These picks offer the best of both worlds. I've selected two dividend stocks that are built to thrive in challenging times, offering elevated income and resilience. These companies are poised for long-term growth. While the market faces obstacles, these picks are strategically positioned to excel in the future. Allow me to share why these stocks are great for what's next.
CME has delivered very strong results for shareholders historically. The company enjoys competitive advantages resulting in high profit margins. CME is likely to benefit from increased interest rate uncertainty.
Financials and materials take focus in today's Big 3, all of which have seen significant upside growth off post-election anticipation. Jessica Inskip joins Rick Ducat to break down the technical trends in CME Group (CME), Blackrock (BLK), and Vulcan Materials (VMC).
CME Group is a top dividend stock with a 61% net margin, recession resilience, and a diverse portfolio of liquid futures markets. Despite new competition, CME's unique products and tight bid-ask spreads ensure a durable competitive edge and strong financial performance. Trading at a blended P/E of 22.5x, CME is undervalued by nearly 30%, offering significant upside potential for long-term growth.
CME's third-quarter results reflect record trading volumes. Average daily volume increased in its six asset classes, with average daily volume up 20% in commodities and 28% in financial markets.
CME Group Inc. (NASDAQ:CME ) Q3 2024 Earnings Conference Call October 23, 2024 8:00 AM ET Company Participants Adam Minick - Head of IR Terrence Duffy - Chairman, CEO Lynne Fitzpatrick - CFO Suzanne Sprague - Senior Managing Director, Global Head of Clearing Julie Winkler - CCO Mike Dennis - Global Head of Fixed Income Tim McCourt - Senior Managing Director, Global Head of Financial Derek Sammann - Senior Managing Director, Global Head of Commodities Conference Call Participants Dan Fannon - Jefferies Chris Allen - Citi Ben Budish - Barclays Ken Worthington - JP Morgan Patrick Moley - Piper Sandler Alex Kramm - UBS Kyle Voigt - KBW Brian Bedell - Deutsche Bank Craig Siegenthaler - Bank of America Owen Lau - Oppenheimer Michael Cyprys - Morgan Stanley Bill Katz - TD Cowen Operator Welcome to the CME Group Third Quarter 2024 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.